We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$144B
AUM Growth
+$27.9B
Cap. Flow
+$22.2B
Cap. Flow %
15.4%
Top 10 Hldgs %
31.02%
Holding
7,740
New
680
Increased
3,884
Reduced
2,259
Closed
408

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Financials 5.68%
3 Healthcare 5.62%
4 Consumer Discretionary 5.04%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZOM
6226
DELISTED
Zomedica Corp.
ZOM
$29K ﹤0.01%
15,454
+12,559
+434% +$26.9K
PTLA
6227
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$29K ﹤0.01%
1,100
-600
-35% -$19.6K
ANY icon
6228
Sphere 3D
ANY
$15.8M
$28K ﹤0.01%
+127
New +$23.9K
ASYS icon
6229
Amtech Systems
ASYS
$264M
$28K ﹤0.01%
5,130
-8,239
-62% -$45.2K
BKD icon
6230
PUT
Brookdale Senior Living
BKD
$3.33B
$28K ﹤0.01%
2,800
-300
-10% -$2.76K
CVEO icon
6231
Civeo
CVEO
$323M
$28K ﹤0.01%
567
-833
-60% -$39K
FLNT
6232
Fluent
FLNT
$122M
$28K ﹤0.01%
2,175
+1,773
+441% +$24.6K
INVE icon
6233
Identive
INVE
$62.4M
$28K ﹤0.01%
4,662
-34
-0.7% -$187
KOF icon
6234
Coca-Cola Femsa
KOF
$23B
$28K ﹤0.01%
454
-1,158
-72% -$70.5K
OSK icon
6235
CALL
Oshkosh
OSK
$9.49B
$28K ﹤0.01%
400
-1,000
-71% -$72K
OVID icon
6236
Ovid Therapeutics
OVID
$482M
$28K ﹤0.01%
4,938
+3,518
+248% +$26.7K
RMTI icon
6237
CALL
Rockwell Medical
RMTI
$28M
$28K ﹤0.01%
61
-288
-83% -$139K
SLAB icon
6238
CALL
Silicon Laboratories
SLAB
$7.23B
$28K ﹤0.01%
300
-3,600
-92% -$352K
SRS icon
6239
CALL
ProShares UltraShort Real Estate
SRS
$16.3M
$28K ﹤0.01%
125
-88
-41% -$19.3K
TEF
6240
CALL
DELISTED
Telefonica
TEF
$28K ﹤0.01%
+4,332
New +$29.6K
WH icon
6241
CALL
Wyndham Hotels & Resorts
WH
$5.38B
$28K ﹤0.01%
500
-100
-17% -$5.72K
HNP
6242
CALL
DELISTED
Huaneng Power Intl, Inc.
HNP
$28K ﹤0.01%
1,100
+600
+120% +$16.2K
RRTS
6243
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$28K ﹤0.01%
1,341
-1,936
-59% -$86K
CEF icon
6244
Sprott Physical Gold and Silver Trust
CEF
$8.04B
$27K ﹤0.01%
2,300
DIOD icon
6245
CALL
Diodes
DIOD
$4.75B
$27K ﹤0.01%
800
-700
-47% -$25.3K
DOG
6246
CALL
ProShares Short Dow30
DOG
$86.9M
$27K ﹤0.01%
500
-2,350
-82% -$134K
ICVT icon
6247
iShares Convertible Bond ETF
ICVT
$7.45B
$27K ﹤0.01%
450
LGND icon
6248
CALL
Ligand Pharmaceuticals
LGND
$6.43B
$27K ﹤0.01%
160
MARA icon
6249
Marathon Digital Holdings
MARA
$3.72B
$27K ﹤0.01%
9,231
+9,225
+153,750% +$34.9K
NWG icon
6250
NatWest
NWG
$76.1B
$27K ﹤0.01%
3,881
-54,600
-93% -$386K

Similar funds

Barclays's Q3 2018 Portfolio in Review

As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.

  • Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
  • Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
  • Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
  • Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
  • Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
  • Barclays opened 680 new positions and closed 408 in Q3 2018.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $144B.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.